| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| S-227928 | S227928; S-227928 | Phase 2 Clinical | Les Laboratoires Servier | Hematologic Neoplasms; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Leukemia, Myeloid, Acute | 詳細 |
| Influenza A M1 vaccine (Pascal Biosciences) | Phase 1 Clinical | Pascal Biosciences | Influenza A virus infections | 詳細 | |
| adenovector based vaccine (Pascal Biosciences/University of British Columbia) | Phase 1 Clinical | Influenza A virus infections | 詳細 | ||
| Bezetabart debotansine | STRO-001; SP7675; SP-7675; BN-301 | Phase 1 Clinical | Sutro Biopharma Inc | Lymphoma, B-Cell; Hematologic Neoplasms; Lymphoma, Large B-Cell, Diffuse; Multiple Myeloma; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin | 詳細 |